Non-muscle-invasive bladder cancer (NMIBC) is a form of bladder cancer that remains within the bladder lining and has not invaded deeper tissues. Standard treatments, such as intravesical (“in-bladder”) Bacillus Calmette-Guérin (BCG) (a live attenuated bacteria) or chemotherapy, are usually effective. However, these treatments may fail to control the disease for some patients.
Latest
News
An update from Shane Quin on immunotherapy treatments for bladder cancer.
Immunotherapy has been an area of significant research in recent years. A plethora of clinical trials have been undertaken investigating their use in the treatment of metastatic bladder cancer. Immune checkpoint inhibitors have emerged as new targeted agents (e.g. pembrolizumab, avelumab, nivolumab) that are used in certain settings.
Australian Cancer Plan
The Federal Government recently (November 2023) launched a 10-year plan to improve the outcomes and lived experience of all people with cancer in Australia. The following six strategic objectives underpin the Plan.
Artificial Intelligence In Bladder Cancer
Artificial intelligence (AI) has been in the spotlight in recent years and is strongly believed to be able to impact all areas of healthcare in the future. Bladder cancer is one area where extensive AI research is being undertaken in diagnosis, recurrence and survival.
Victorian Government survey on cancer planning
This Victorian Government survey on cancer planning for the next 4 years is really valuable if it’s a big sample. Please take the time to do it. It’s open to all people affected by cancer. “People affected by cancer, sector stakeholders and interested Victorians are invited to complete a survey on Engage Victoria to identify […]
This week is Urology Week!
Urology Week is an annual international campaign Urology Week is an international campaign for increasing awareness of urological conditions and treatment. This year (26-30 September 2021) the focus is on blood in urine as an indicator for bladder cancer. We encourage everyone to spread the word about blood in urine and how important it is […]
New Board Member – Dr Sachin Perera
Sachin Perera is one of the newest members to join the bladdercancer.org.au board in 2022. Sachin is a junior doctor based at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre in Parkville, Victoria with a focus of practice in urology. As an aspirational Urologist he works closely with leaders in the field to deliver research and […]
USANZ22 EKO Guitar Winner
The Bladder Cancer Australia Charity Foundation guitar prize is fast becoming a popular convention must do at at USANZ. Delegates visiting our convention booth for our latest bladder cancer patient literature and other resources also sign up for a chance to win our guitar prize. The lucky winner this year is Nick Davies from Tasmania! […]
BladderCancer.org.au at USANZ22
The Urological Society of Australia and New Zealand 2022 Conference We are distributing our Bladder Cancer Patient Guidebook and other patient resources at USANZ22 Our booth also has a draw going for an EKO EVO III D EQ guitar valued at $899.00 Note that there are costs involved in attending a conference like this and […]
Embarrassing Affirmations (Video)
May is #BladderCancerMonth22 🗓️ We are challenging taboos and sparking conversations about most common symptom of bladder cancer – blood in urine. Embarrassment shouldn’t be what stops us from sharing the concern with others, especially a doctor. Some things we’re embarrassed about are harmless. Some, might not be. If you see blood in your urine, […]
Bladder Cancer & Smoking Study
This recent study by Marc Diocera gives more weight to smoking being a major factor in bladder cancer illness. Study Details Substantial changes in the prevalence of the principal kidney and bladder cancer risk factors, smoking (both cancers) and body fatness (kidney cancer), have occurred but the contemporary cancer burden attributable to these factors has […]
Monash University Study – $20 Coles voucher offer
Eligible participants: Have been diagnosed with cancer (any type) in the last three years Speak English as their primary language Are aged 18+ years Participants will be required to answer a brief screening email and complete an online survey, that should take 20-30 mins. Upon completion, they will then receive a $20 Coles voucher for their time. Sidney Davies School of […]